Warby Parker Inc. WRBY
We take great care to ensure that the data presented and summarized in this overview for Warby Parker Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding WRBY
View all-
D1 Capital Partners L.P. New York, NY14.9MShares$247 Million3.88% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.68MShares$143 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.92MShares$114 Million0.0% of portfolio
-
Baillie Gifford & CO6.08MShares$100 Million0.07% of portfolio
-
General Catalyst Group Management, LLC5.66MShares$93.5 Million6.28% of portfolio
-
Durable Capital Partners LP Bethesda, MD4.15MShares$68.7 Million0.46% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.06MShares$67.1 Million0.03% of portfolio
-
State Street Corp Boston, MA2.28MShares$37.6 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.08MShares$34.4 Million0.74% of portfolio
-
Geode Capital Management, LLC Boston, MA1.75MShares$28.9 Million0.0% of portfolio
Latest Institutional Activity in WRBY
Top Purchases
Top Sells
About WRBY
Warby Parker Inc. provides eyewear products. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as accessories, including cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray. The company also offers eye exams and vision tests directly to consumers through its retail stores, website, and mobile apps. As of May 16, 2022, it had 160 retail stores in the United States and Canada. The company was formerly known as JAND, Inc. and changed its name to Warby Parker Inc. in June 2021. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.
Insider Transactions at WRBY
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 11
2024
|
Steven Clive Miller Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
24,225
-12.68%
|
$266,475
$11.98 P/Share
|
Mar 08
2024
|
David Abraham Gilboa Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
52,065
-80.88%
|
$624,780
$12.2 P/Share
|
Mar 08
2024
|
David Abraham Gilboa Co-Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
52,065
+44.72%
|
-
|
Mar 07
2024
|
Neil Harris Blumenthal Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-80.42%
|
$600,000
$12.4 P/Share
|
Mar 07
2024
|
Neil Harris Blumenthal Co-Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
50,000
+44.57%
|
-
|
Mar 06
2024
|
David Abraham Gilboa Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
28,311
-69.7%
|
$311,421
$11.88 P/Share
|
Mar 06
2024
|
David Abraham Gilboa Co-Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
28,311
+41.07%
|
-
|
Mar 06
2024
|
Neil Harris Blumenthal Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
28,311
-69.92%
|
$311,421
$11.88 P/Share
|
Mar 06
2024
|
Neil Harris Blumenthal Co-Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
28,311
+41.15%
|
-
|
Mar 06
2024
|
Steven Clive Miller Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,708
-4.36%
|
$95,788
$11.88 P/Share
|
Mar 06
2024
|
Steven Clive Miller Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,159
+9.58%
|
-
|
Mar 05
2024
|
Neil Harris Blumenthal Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
16,731
-57.88%
|
$200,772
$12.12 P/Share
|
Mar 05
2024
|
David Abraham Gilboa Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
16,731
-57.62%
|
$200,772
$12.12 P/Share
|
Mar 05
2024
|
Steven Clive Miller Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,963
-4.78%
|
$107,556
$12.12 P/Share
|
Mar 04
2024
|
Neil Harris Blumenthal Co-Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,802
+49.91%
|
-
|
Mar 04
2024
|
David Abraham Gilboa Co-Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,802
+49.8%
|
-
|
Mar 04
2024
|
Steven Clive Miller Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,737
+9.95%
|
-
|
Dec 14
2023
|
Steven Clive Miller Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,875
-6.12%
|
$130,500
$12.22 P/Share
|
Dec 11
2023
|
Steven Clive Miller Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
21,550
-10.81%
|
$237,050
$11.42 P/Share
|
Dec 08
2023
|
Steven Clive Miller Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,760
-3.75%
|
$77,600
$10.56 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 212K shares |
---|---|
Exercise of conversion of derivative security | 80.9K shares |
Conversion of derivative security | 291K shares |
Open market or private sale | 1.78M shares |
---|